Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 10/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 4/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL631172 | 0.80 | NAAA (0.45) | NAAANOTUMFAAHPIK3CD | |
| SCHEMBL1027659 | 0.79 | — | — | |
| SCHEMBL787654 | 0.78 | NAAA (0.44) | NAAANOTUMFAAHPIK3CD | |
| SCHEMBL787653 | 0.78 | NAAA (0.44) | NAAANOTUMFAAHPIK3CD | |
| SCHEMBL11449421 | 0.77 | NAAA (0.44) | NAAAFAAH | |
| SCHEMBL15537754 | 0.76 | NAAA (0.41) | NAAANOTUMFAAH | |
| SCHEMBL11447863 | 0.75 | NAAA (0.43) | NAAAFAAH | |
| SCHEMBL7569177 | 0.73 | NAAA (0.48) | NAAAFAAH | |
| SCHEMBL9311219 | 0.72 | — | — | |
| SCHEMBL3130166 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2861559-B1 | METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE | UNIV OF EAST ANGLIA (GB) | 2020-09-16 | — | — | EP | disclosed |
| US-10259784-B2 | Method and catalyst for synthesising aziridine | UNIVERSITY OF EAST ANGLIA (GB) | 2019-04-16 | — | — | US | disclosed |
| US-20170342030-A1 | METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE | UNIV OF EAST ANGLIA (GB) | 2017-11-30 | — | — | US | disclosed |
| US-9732034-B2 | Method and catalyst for synthesising aziridine | UNIVERSITY OF EAST ANGLIA (GB) | 2017-08-15 | — | — | US | disclosed |
| US-20170152225-A9 | METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE | UNIVERSITY OF EAST ANGLIA (GB) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10259784-B2 | Method and catalyst for synthesising aziridine | ITPA, PPA1, PPIP5K2 | NAAA 15/4885NOTUM 1771/4885FAAH 2499/4885 |
| US-20170342030-A1 | METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE | ITPA, PPA1, PPIP5K2 | NAAA 15/4885NOTUM 1771/4885FAAH 2499/4885 |
| US-20170152225-A9 | METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE | ITPA, PPA1, PPIP5K2 | NAAA 19/4885NOTUM 1561/4885FAAH 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.